hotspot -WSS

hotspot

author：entertainment 2025-10-01 18:07:51 - browse：41262

Novo Nordisk headquarters -- health coverage from STAT — Novo Nordisk's headquarters, outside Copenhagen, Denmark. LISELOTTE SABROE/Scanpix/AFP via Getty Images

Novo Nordisk is pausing ads for its obesity drug Wegovy as it struggles to keep up with surging demand, the latest hurdle in its rollout of the weight loss drug.

“To avoid stimulating further demand for this medicine, we’re pausing some key Wegovy promotional efforts,” the Danish drugmaker said in an emailed statement. “We are pausing all local television advertising and postponing planned national television advertising for Wegovy. We are also assessing our promotional efforts to healthcare professionals and adjusting accordingly.” The news was earlier reported by Endpoints.

Wegovy, which contains the active ingredient semaglutide, has become immensely popular for its effectiveness in helping people lose weight and is helping usher in what many see as a sea change in obesity treatment. Its sister drug for diabetes, Ozempic, has also been in demand for a similar effect on weight loss.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Israel withdraws forces after 2

hotspot

WSS

Search warrant issued in 1996 disappearance of Kristin Smart

No plane should take off without an EpiPen onboard

3 protesters arrested at Wimbledon after interrupting matches by throwing confetti on court

Wildfire pollution widens asthma inequities on Long Island

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Gov. Ron DeSantis' push for 'civics' education: What does it look like?

entertainment

hotspot

leisure time

Affirmative action in medical school literally saved lives

The leaders of Italy and Poland say European Union should focus on stopping migration

At least 13 dead in Texas as scorching temps continue

Former New York Mayor de Blasio and wife announce separation, but not divorce

The cancer drug shortage isn’t new — and neither are the solutions

NIH launches clinical trials and new research office for long Covid

Psychedelics group wrestles with new pharma identity

The high personal cost of affirmative action for Black doctors

In Memoriam: Notable people who died in 2023

'Insanity': 4th of July mass shootings across US kill 13, injure more than 80

leisure time

5 important ways Henrietta Lacks changed medical science

A bus careens into a gulch in southern Mexico, leaving 27 people dead

Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

5 important ways Henrietta Lacks changed medical science

EQRx, failed developer of low

Amazon expands telehealth clinic nationwide

focus

hotspot

focus

hotspot